ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Differences in clinical presentation and treatment decisions between frail and not-frail head and neck cancer patients.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study evaluated if patient presentation, treatment decisions and oncologic outcomes were different among frail vs. not-frail patients presenting with a new head and neck cancer.
methodsA single-centre retrospective cohort study was conducted including consecutive patients presenting with a new mucosal head and neck SCC over a 1-year period. Frailty was calculated using the 5 item modified frailty index (5mFI).
resultsTwo-hundred and thirty-two patients were included with 61 patients (26.3%) being frail using the 5mFI. Frail patients were older (70.6 years vs. 61.9 years; p < 0.001) and more likely to present with T3/4 disease (65.7% vs. 49.1%; p = 0.027). Frail patients were more likely to receive palliative intent treatment (16.4% vs. 4.7%; p = 0.003). Among patients managed with curative intent, there were differences in treatments received (p = 0.022). Three-year overall survival (OS) (76.7% vs.49.7%; p < 0.001) and 3-year disease free survival (DFS) (71.1% vs. 38.9%; p < 0.001) was significantly reduced among frail patients.
conclusionOver one-quarter of patients with new mucosal SCCs were frail. Frail patients presented with more advanced primary tumours. Frailty was associated with significantly worse 3-year OS and DFS and was associated with differences in treatment intent. LEVEL OF EVIDENCE: III.
Indexed as
Identifiers
42637847What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.